Fig. 10From: Mesenchymal stem cells promote glioma neovascularization in vivo by fusing with cancer stem cellsStem cell features of fusion cells. a: the ratio of CD133+ cells in FCs was 2.67 ± 0.35%, and the ratio of CD133+ cells in SU3-RFP was 1.05 ± 0.18% by flow cytometry; b-c: RT-PCR showed that the expression of stem cell-associated transcription factors Oct4, Sox2, and Nanog was also increasedBack to article page